Life changing creativity is what the Cannes Lions Festival is all about. It is wonderful to see the health and wellness industry getting engaged in creating and celebrating creativity and innovation on a global stage.
Dayton, N.J., October 22, 2015 – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg. […]
Loneliness accelerates cognitive decline in older adults, says a research team presenting at the Alzheimer’s Association International Conference in Washington, D.C. The findings build on recent research indicating that late-life depression […]
Sometimes data just speaks for itself. But more often, its left to scientists and journalists to try and draw useful conclusions from complex observations. And so is the case with […]
Alzheimer’sAxovant, a drug company created by former hedge fund manager Vivek Ramaswamy, has become a battleground stock because some critics can’t believe the company’s experimental Alzheimer’s drug, RVT-101, could possibly […]
New data being presented this morning on experimental Alzheimer’s drugs from Biogen and Eli Lilly are likely to leave researchers and investors slightly disappointed, while not changing anyone’s mind about […]
Researchers will provide clues about whether Eli Lilly & Co.’s risky bet on an experimental drug for Alzheimer’s disease ultimately pays off—for patients and for Lilly’s bottom line. Scientists are […]
Paul Allen, philanthropist and co-founder of Microsoft, has devoted many millions of dollars to unlocking the mysteries of the brain, and today he’s taking on a new challenge: Alzheimer’s disease. […]
Korea’s startup landscape remains partial to gaming. Demand has been growing at such a staggering clip that the industry now accounts for 90% of the country’s mobile app revenues. The […]
Results from an extensive new study suggest that early symptoms of Alzheimer’s disease appear up to 18 years before the disease is officially diagnosed. Researchers publishing in the journal Neurology […]
